Plasma biomarkers of oxidative stress: Relationship to lung disease and inhaled nitric oxide therapy in premature infants

Philip L. Ballard, William E. Truog, Jeffrey D. Merrill, Andrew Gow, Michael Posencheg, Sergio G. Golombek, Lance A. Parton, Xianqun Luan, Avital Cnaan, Roberta A. Ballard

Research output: Contribution to journal › Article › peer-review

43 Citations (Scopus)

Abstract

Objectives. Inhaled nitric oxide treatment for ventilated premature infants improves survival without bronchopulmonary dysplasia. However, there has been no information regarding possible effects of this therapy on oxidative stress. We hypothesized that inhaled nitric oxide therapy would not influence concentrations of plasma biomarkers of oxidative stress. Patients and Methods. As part of the Nitric Oxide Chronic Lung Disease Trial, we collected blood samples at specified intervals from a subpopulation of 100 infants of

Original language	English
Pages (from-to)	555-561
Number of pages	7
Journal	Pediatrics
Volume	121
Issue number	3
DOIs	https://doi.org/10.1542/peds.2007-2479
Publication status	Published - Mar 2008
Externally published	Yes

Keywords

3-nitrotyrosine
Bronchopuimonary dysplasia
Carbonyl
Nitric oxide
Premature infant

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1542/peds.2007-2479

Fingerprint Dive into the research topics of 'Plasma biomarkers of oxidative stress: Relationship to lung disease and inhaled nitric oxide therapy in premature infants'. Together they form a unique fingerprint.

Cite this

Plasma biomarkers of oxidative stress : Relationship to lung disease and inhaled nitric oxide therapy in premature infants. / Ballard, Philip L.; Truog, William E.; Merrill, Jeffrey D.; Gow, Andrew; Posencheg, Michael; Golombek, Sergio G.; Parton, Lance A.; Luan, Xianqun; Cnaan, Avital; Ballard, Roberta A.

In: Pediatrics, Vol. 121, No. 3, 03.2008, p. 555-561.

Research output: Contribution to journal › Article › peer-review

@article{2ba26867f5674c2bb0532a7cc3a9a230,

title = "Plasma biomarkers of oxidative stress: Relationship to lung disease and inhaled nitric oxide therapy in premature infants",

abstract = "Objectives. Inhaled nitric oxide treatment for ventilated premature infants improves survival without bronchopulmonary dysplasia. However, there has been no information regarding possible effects of this therapy on oxidative stress. We hypothesized that inhaled nitric oxide therapy would not influence concentrations of plasma biomarkers of oxidative stress. Patients and Methods. As part of the Nitric Oxide Chronic Lung Disease Trial, we collected blood samples at specified intervals from a subpopulation of 100 infants of ",

keywords = "3-nitrotyrosine, Bronchopuimonary dysplasia, Carbonyl, Nitric oxide, Premature infant",

author = "Ballard, {Philip L.} and Truog, {William E.} and Merrill, {Jeffrey D.} and Andrew Gow and Michael Posencheg and Golombek, {Sergio G.} and Parton, {Lance A.} and Xianqun Luan and Avital Cnaan and Ballard, {Roberta A.}",

year = "2008",

month = mar,

doi = "10.1542/peds.2007-2479",

language = "English",

volume = "121",

pages = "555--561",

journal = "Pediatrics",

issn = "0031-4005",

publisher = "American Academy of Pediatrics",

number = "3",

}

TY - JOUR

T1 - Plasma biomarkers of oxidative stress

T2 - Relationship to lung disease and inhaled nitric oxide therapy in premature infants

AU - Ballard, Philip L.

AU - Truog, William E.

AU - Merrill, Jeffrey D.

AU - Gow, Andrew

AU - Posencheg, Michael

AU - Golombek, Sergio G.

AU - Parton, Lance A.

AU - Luan, Xianqun

AU - Cnaan, Avital

AU - Ballard, Roberta A.

PY - 2008/3

Y1 - 2008/3

N2 - Objectives. Inhaled nitric oxide treatment for ventilated premature infants improves survival without bronchopulmonary dysplasia. However, there has been no information regarding possible effects of this therapy on oxidative stress. We hypothesized that inhaled nitric oxide therapy would not influence concentrations of plasma biomarkers of oxidative stress. Patients and Methods. As part of the Nitric Oxide Chronic Lung Disease Trial, we collected blood samples at specified intervals from a subpopulation of 100 infants of

AB - Objectives. Inhaled nitric oxide treatment for ventilated premature infants improves survival without bronchopulmonary dysplasia. However, there has been no information regarding possible effects of this therapy on oxidative stress. We hypothesized that inhaled nitric oxide therapy would not influence concentrations of plasma biomarkers of oxidative stress. Patients and Methods. As part of the Nitric Oxide Chronic Lung Disease Trial, we collected blood samples at specified intervals from a subpopulation of 100 infants of

KW - 3-nitrotyrosine

KW - Bronchopuimonary dysplasia

KW - Carbonyl

KW - Nitric oxide

KW - Premature infant

UR - http://www.scopus.com/inward/record.url?scp=40949144900&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40949144900&partnerID=8YFLogxK

U2 - 10.1542/peds.2007-2479

DO - 10.1542/peds.2007-2479

M3 - Article

C2 - 18310205

AN - SCOPUS:40949144900

VL - 121

SP - 555

EP - 561

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 3

ER -